Canabolabs
Treatment of Chronic and Malignant Diseases
Non Active, Jun 2019 ceased to operate
Company Overview
Snapshot
Founded in April 2017, Canabolabs operated with 1–10 employees, focusing on pharmaceutical research and development. The company ceased operations in June 2019.
Business overview
Canabolabs was an international pharmaceutical company specializing in the research and development of medicines derived from natural sources. The company focused on developing technologies and patents for medicinal release, creating delivery methods to ease consumption for patients who struggled with conventional medicine while maintaining clinical efficiency. Canabolabs operated within the Pharmaceuticals sector, specifically targeting the medical cannabis, biopharmaceutical, and drug discovery markets.
Log in to access full profile ›Company Intelligence Q&A
- What was Canabolabs' primary focus?
- Canabolabs specialized in the research and development of medicines derived from natural sources and the creation of technologies for medicinal release.
- When was Canabolabs founded?
- Canabolabs was founded in April 2017.
- What was the operational status of Canabolabs?
- Canabolabs ceased to operate in June 2019.
- What types of products did Canabolabs develop?
- Canabolabs developed products such as Cannabol drops, Cannabol forte, Cannabol night, Cannabol active, Cannabol Inhaler, and Cannabol comfort.
- In which geographical market did Canabolabs primarily operate?
- Canabolabs primarily operated in the Israeli market.